SCHEMBL7230655

SCHEMBL7230655

CCCC(C)NC(=O)C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
HPGD P15428 1/20 0.46
MLYCD O95822 1/20 0.43
POLB P06746 2/20 0.42
ESR1 P03372 1/20 0.42
KCNH2 Q12809 1/20 0.42
EPHX1 P07099 1/20 0.41
KMT2A Q03164 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
TAS1R3 Q7RTX0 2/20 0.37
TAS1R1 Q7RTX1 2/20 0.37
TAS1R2 Q8TE23 1/20 0.37
LMNA P02545 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
THRB P10828 1/20 0.36
ELANE P08246 1/20 0.36
CA2 P00918 1/20 0.36
CTSK P43235 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7045874 0.86 MLYCD (0.57) MLYCDESR1KCNH2EPHX1KMT2A
SCHEMBL9344459 0.83 SMN1; SMN2 (0.47) ALDH1A1MLYCDPOLBESR1KCNH2
SCHEMBL7230653 0.82 ESR1 (0.41) ALDH1A1HPGDMLYCDPOLBESR1
SCHEMBL23613007 0.81 ALDH1A1 (0.43) ALDH1A1HPGDPOLBKMT2ANPC1
SCHEMBL27547888 0.81 TAS1R3 (0.44) ALDH1A1POLBEPHX1TAS1R3TAS1R1
SCHEMBL566465 0.80 MLYCD (0.41) ALDH1A1MLYCDPOLBESR1KCNH2
SCHEMBL995905 0.80 MLYCD (0.43) ALDH1A1MLYCDPOLBESR1KCNH2
SCHEMBL566464 0.80 MLYCD (0.41) ALDH1A1MLYCDPOLBESR1KCNH2
SCHEMBL864396 0.79 EPHX1 (0.41) ALDH1A1MLYCDPOLBESR1KCNH2
SCHEMBL28253440 0.79 EPHX1 (0.41) ALDH1A1MLYCDPOLBESR1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6534503-B1 Treating sexual dysfunction, such as erectile dysfunction or sexual arousal disorder, with a compound having the generic formula X1-X2-(D)Phe-Arg-(D)Trp-X3. A particularly useful compound is HP-228, which has the formula LION BIOSCIENCE AG (DE) 2003-03-18 US claimed
EP-1214330-A1 BENZIMIDAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF LION Bioscience AG (DE) 2002-06-19 EP claimed
WO-2001021634-A1 BENZIMIDAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF LION BIOSCIENCE AG (DE) 2001-03-29 WO claimed
EP-1214330-A1 BENZIMIDAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF LION Bioscience AG (DE) 2002-06-19 EP disclosed
WO-2001021634-A1 BENZIMIDAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF LION BIOSCIENCE AG (DE) 2001-03-29 WO disclosed